DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
In a close collaboration with the NCI Division of Cancer Control and Population Sciences (DCCPS), investigators in DCEG recently completed the migration of historical U.S. mortality data from the NCI Cancer Mortality Maps (CMM) website to GeoViewer, a visualization mapping tool that until now only displayed the most recent five years of data. Learn more about the expanded GeoViewer tool.
The American Heart Association Lifestyle and Cardiometabolic Health Council recognized the work of former DCEG fellow Dr. Hannah Arem and Charles E. Matthews, Ph.D., for their study entitled “Leisure time physical activity and mortality: A detailed pooled analysis of the dose‐response relationship.” The paper was selected as one of the most important publications in 2015 in support of the Council’s mission. Read more about this honor.
Lindsay Morton, Ph.D., has been appointed to serve a two-year term as Women Scientist Advisor (WSA) to Division Director Stephen J. Chanock, M.D. In this role Dr. Morton will advise the director on issues relevant to women scientists and engage with her peers on a wide range of topics to enhance and improve the workplace for women scientists in the division. Read more about Dr. Morton.
In March 2016, Jackie Lavigne, Ph.D., M.P.H, Chief of the Office of Education, was recognized in Cancer for her contributions to promote diversity within the biomedical workforce at NCI and beyond. Dr. Lavigne collaborates with others across NIH to promote diversity through a number of outreach, recruitment, and retention programs. Read more about Dr. Lavigne.
Louise A. Brinton, Ph.D., M.P.H., has been appointed Scientific Advisor for International Activities in the DCEG Office of the Director. In this new position, Dr. Brinton will utilize her extensive experience in leading epidemiologic studies around the globe. Read more about Dr. Brinton.
In recognition of Rare Disease Day 2016, Sharon Savage, M.D., Chief of the Clinical Genetics Branch, discussed her research on Li-Fraumeni Syndrome (LFS) at a day-long symposium hosted by NIH. Her talk, which was titled “Bench to Bedside Update: Telomeres in Li-Fraumeni Syndrome,” was recorded. Read more about Dr. Savage's talk and watch a video of her presentation.
In March, Charles E. Matthews, Ph.D., was awarded scientific tenure by the NIH. Dr. Matthews studies the relationship between physical activity behaviors and the development of cancer. In particular he seeks to understand how the full spectrum of physical activity behaviors influences cancer risk. Read more about Dr. Matthews and his research.
Ethel S. Gilbert, Ph.D., staff scientist in the Radiation Epidemiology Branch (REB), retired after nearly 20 years at NCI. She is internationally recognized for her outstanding contributions to statistical methodology for radiation epidemiology studies. Read more about Dr. Gilbert and her research accomplishments.
Joseph F. Fraumeni, Jr., M.D., former Director of DCEG, has been honored by the American Society of Preventive Oncology (ASPO), whose Executive Committee unanimously voted to rename its Distinguished Career Achievement Award as the ASPO Joseph F. Fraumeni, Jr., Distinguished Achievement Award. This award celebrates and acknowledges public health scientists who have made significant contributions to cancer research and prevention. Read more about Dr. Fraumeni and the ASPO award.
On January 12, 2016, DCEG scientists participated in the annual NCI Intramural Scientific Investigators Retreat. Mary H. Ward, Ph.D., received the NCI Women Scientist Advisors' Mentoring and Leadership Award. Montserrat Garcia-Closas, M.D., Dr.P.H., Gretchen Gierach, Ph.D., and Charles E. Matthews, Ph.D., gave presentations highlighting their research. Read more about the retreat.
Several DCEG staff members were honored for their outstanding mentoring, leadership, and commitment to NCI at the Director’s Awards ceremony in November. Read more about this year's honorees.
Christian C. Abnet, Ph.D., M.P.H., has been appointed Chief of the newly established Metabolic Epidemiology Branch (MEB). MEB is the result of a merger of the Hormonal and Reproductive Epidemiology Branch and the Nutritional Epidemiology Branch (NEB). The new MEB will focus on enhanced scientific collaboration on research themes shared by principal investigators from the two original Branches. Read more about Dr. Abnet.
In November, Neal D. Freedman, Ph.D., M.P.H., was awarded scientific tenure by the NIH. Dr. Freedman conducts multidisciplinary epidemiologic studies to investigate the role of lifestyle and metabolic factors in cancer etiology, in particular the mechanisms by which tobacco products cause cancer and the risk factors for liver cancer. Read more about Dr. Freedman and his research.
Gloria M. Petersen, Ph.D., Professor of Epidemiology at the Mayo Clinic College of Medicine and Associate Director for Population Sciences Research, Mayo Clinic Cancer Center, gave a DCEG Visiting Scholar lecture in October 2015. Her talk was titled “Recent advances in genetics and risk assessment of pancreatic cancer.” Read more about Dr. Petersen's lecture.
In November, DCEG Director Stephen J. Chanock, M.D., held a Town Hall Meeting to commend the recent accomplishments of both scientific and administrative support staff and to provide an update on Division activities. Each year, the Division recognizes individuals who have gone above and beyond the call of duty to provide outstanding service to their Office, Branch, or the Division as a whole. DCEG Special Appreciation Awards were given to Sarah Wagner, Cancer Genomics Research Laboratory, and Sharon Coles-Calloway, Administrative Resource Center. Read more about the Town Hall Meeting.
DCEG Intramural Research Awards (IRAs) are competitive funding opportunities designed to foster creative, high-impact research by fellows and tenure-track investigators. Proposals are evaluated on their potential for significant scientific or public health impact, innovation, interdisciplinary nature, ability to achieve the objectives within the proposed time frames and with the proposed resources, and programmatic relevance to DCEG’s mission. Find out about this year's winning IRA proposals.
In October 2015, Michael C. R. Alavanja, Dr.P.H., retired after more than 30 years with NCI. Dr. Alavanja is a leading expert in environmental and occupational epidemiology, particularly recognized for his work to identify pesticide exposures that may be responsible for excess cancer risk among farmers. He was a senior investigator in the Occupational and Environmental Epidemiology Branch and a member of the U.S. Public Health Service (retired in 2008). Read more about Dr. Alavanja.
In October 2015, Jennifer T. Loud, R.N., C.R.N.P., D.N.P., Assistant Chief of the Clinical Genetics Branch, received the NCI John P. Hartinger Leadership Development Award. This award is competitively awarded each year to an NCI employee in recognition of leadership potential, commitment to public service, and desire to further his/her executive development. Read more about Dr. Loud's award.
Nilanjan Chatterjee, Ph.D., departed in September from the Biostatistics Branch after 16 years with NCI. In his new position he will serve as a Bloomberg Distinguished Professor at the Johns Hopkins University with joint appointments at the Bloomberg School of Public Health (Biostatistics) and the School of Medicine (Oncology). Learn more about Dr. Chatterjee.
In October, Lindsay Morton, Ph.D., was awarded scientific tenure by the NIH. Dr. Morton investigates the causes of and risk factors for second primary malignancies and non-Hodgkin lymphoma (NHL). Read more about Dr. Morton and her research.
Sholom Wacholder, Ph.D., biostatistician and senior investigator in the Biostatistics Branch, died October 4, 2015, at his home in Rockville, Maryland. "Dr. Wacholder made tremendous contributions to the fields of cancer epidemiology and biostatistics as well as to his community of colleagues at NCI and to those whom he mentored," said Dr. Stephen Chanock, Divsion Director. "He will be greatly missed by all of us. He was a special colleague and friend to so many." Read more about Dr. Wacholder.
Martha S. Linet, M.D., M.P.H., was featured in the Sep/Oct 2015 issue of the NIH Fogarty International Center Global Health Matters newsletter. The article, titled “Benzene research in China informs EPA regulations,” described how scientists at NCI and China’s Center for Disease Control have been studying benzene’s effects on Chinese factory workers for nearly 30 years. The collaborative research has benefited public health by reducing levels of exposure to this known carcinogen. Read the article in Fogarty’s Global Health Matters newsletter.
Montserrat García-Closas, M.D., Dr.P.H., has been appointed Deputy Director of DCEG. Dr. García-Closas is an internationally recognized expert in the use of biomarkers, sophisticated exposure assessment, and rigorous methodology in large-scale epidemiological studies to investigate of the causes of breast and bladder cancers. Read more about Dr. García-Closas.
Nine winners have been announced for the 2015 DCEG Informatics Tool Challenge, building on the successful launch of the Challenge in 2014. Submissions were evaluated for their innovative use of current technologies to address a specific research need, the ability for the project to be completed within one year of initiation, and the cost, which was not to exceed $20,000. Find out more about the 2015 Informatics Tool Challenge winning submissions.
In July 2015, Mark Purdue, Ph.D., rejoined DCEG after serving as the Executive Scientific Director of the Ontario Health Study in in Toronto, Canada. Dr. Purdue returned as a tenure-track investigator in the Occupational and Environmental Epidemiology Branch. His interests center on applying molecular and classical epidemiologic methods to study the causes of cancer and to improve exposure assessment. In particular, he investigates the etiology of non-Hodgkin lymphoma and kidney cancer, and evaluates the potential carcinogenicity of trichloroethylene and other chlorinated solvents. Learn more about Dr. Purdue.
In May, Stephen J. Chanock, M.D., DCEG Director, delivered a talk at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. He spoke on “Risks and benefits of real-time molecular profiling” during an education session on “Real-time molecular genetic profiling: The future is now (or is it)?”.